Normal thrombopoietin and its receptor (c-mpl) genes in children with essential thrombocythemia

Pediatric Blood and Cancer

Volumn 44, Issue 1, 2005, Pages 47-50

  Randi, M L ^a,b   Putti, M C ^a   Pacquola, E ^a   Luzzatto, G ^a   Zanesco, L ^a   Fabris, F ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Ospedale 105   (Italy)

Author keywords

c mpl; Essential thrombocythemia; Thrombopoietin

Indexed keywords

THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR;

ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; DNA EXTRACTION; DNA FLANKING REGION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENETIC CODE; GENOME; HUMAN; INFANT; INTRON; MALE; MEASUREMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

ADOLESCENT; CHILD; DNA; FEMALE; HUMANS; INFANT; MALE; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOPOIETIN;

EID: 10044265584     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20185     Document Type: Article

References (29)

1. Murphy S. Thrombocytosis and thrombocythemia. Clin Haematol 1983;12:89-106.
2. Michiels JJ, Van Genderen PJJ. Essential thrombocythemia in childhood. Semin Thromb Hemostas 1997;23:295-301.
3. Randi ML, Fabris F, Girolami A. Leukemia and myelodysplasia: Effect of multiple cytotoxic therapy in essential thrombocythemia. Leuk Lymph 1997;37:379-385.
4. Sutor AH. Thrombocytosis in childhood. Semin Thromb Hemostas 1997;21:330-339.
5. Randi ML, Stocco F, Rossi C, et al. Thrombosis and hemorrhage in thrombocytosis: Evaluation of a large cohort of patients (357 cases). J Med 1991;22:213-223.
6. Fialkow PS, Fogue GB, Jacobson RJ, et al. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981;58:916-919.
7. Harrison CN, Gale RE, Machin SJ, et al. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood 1999;93:417-424.
8. Randi ML, Putti MC, Fabris F, et al. Features of essential thrombocythemia in childhood: A study of five children. Br J Haematol 2000;108:86-89.
9. Kralowics R, Buser AS, Teo SS, et al. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood 2003;102:1869-1871.
10. Ghilardi N, Wiestner A, Kikuchi M, et al. Hereditary thrombocythemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene. Br J Haematol 1999;107:310-316.
11. Kondo TG, Okabe M, Sanada M, et al. Familial essential thrombocythemia associated with one-base deletion in the 5′-untranslated region of the thrombopoietin gene. Blood 1998;100:383-386.
12. Taksin AL, Couedic JPL, Dusanter-Fourt I, et al. Autonomous megacaryocytes growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by mpl-L. Blood 1999;93:125-139.
13. Murphy S, Iland H, Rosenthal D, et al. Essential thrombocythemia: An interim report from the polycythemia vera study group. Semin Hematol 1986;23:177-182.
14. Thiele J, Kvasnicka HM, Zankovich R, et al. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. Haematologica 2000;85:1126-1134.
15. Harrison CN, Green AR. Essential thrombocythemia. Hematol Oncol Clin North Am. 2003;17:1175-1190.
16. Adeyinka A, Dewald GW. Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes. Hematol Oncol North Am 2003;110:104-109.
17. Wiestner A, Padosch SA, Ghilardi N, et al. Hereditary thrombocythemia is a genetically heterogeneous disorder: Exclusion of TPO and mpl in two families with hereditary thrombocythemia. Br J Haematol 2000;110:104-109.
18. Foster DC, Sprecher CA, Grant FJ, et al. Human thrombopoietin: Gene structure, cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA 1994;91:13023-13027.
19. Kaushanski K. Thrombopoietin: The primary regulator of platelet production. Blood 1995;86:419-431.
20. Nagasawa T, Hasegawa Y, Shimizu S, et al. Serum thrombopoietin level is mainly regulated by megakaryocyte mass rather then platelet mass in human subjects. Br J Haematol 1998;101:242-244.
21. Ichikara N, Ishida F, Shimodaira S, et al. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anemia and idiopathic thrombocytopenic purpura. Thromb Haemostas 1996;76:156-160.
22. Tahara T, Usuki K, Sato H, et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: Serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br J Haematol 1996;93:783-788.
23. Wiestner A, Schlemper RJ, van der Maas APC, et al. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia. Nat Genet 1998;18:49-52.
24. Harrison CN, Gale RE, Wiestner AC, et al. The activating splice mutation in intron 3 of thrombopoietin gene is not found in patients with non-familial essential thrombocythemia. Br J Haematol 1998;102:1341-1343.
25. Moliterno AR, Hankins WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New Engl J Med 1998;338:572-580.
26. Harrison CN, Gale RE, Pezella F, et al. Platelet c-mpl expression is dysregulated in patients with essential thrombocythemia but this is not of diagnostic value. Br J Haematol 1999;107:139-147.
27. Moliterno AR, Williams DM, Gutierrez LI, et al. Thrombopoietin receptor polymorphism associated with thrombocytosis. Blood 2000;100:586a.
28. Yoshida N, Ishii E, Koga N, et al. Analysis of thrombopoietin and c-mpl expression in a child with essential thrombocythemia. Ped Hematol Oncol 1998;15:359-363.
29. Pastore YD, Jelinek J, Ang S, et al. Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood 2003;101:1591-1595.